Resistance to cotrimoxazole and other antimicrobials among isolates from HIV/AIDS and Non-HIV/AIDS patients at bugando medical centre, Mwanza, Tanzania

AIDS Research and Treatment

Volumn 2015, Issue , 2015, Pages

  Marwa, Karol J ^a   Mushi, Martha F ^a   Konje, Eveline ^b   Alele, Paul E ^c   Kidola, Jeremiah ^d   Mirambo, Mariam M ^a  

^a WEILL BUGANDO SCHOOL OF MEDICINE   (Tanzania)

^b CATHOLIC UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84924533906     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2015/103874     Document Type: Article

References (62)

1. I. N. Okeke, R. Laxminarayan, Z. A. Bhutta et al., "Antimicrobial resistance in developing countries. Part I: recent trends and current status," The Lancet Infectious Diseases, vol. 5, no. 8, pp. 481-493, 2005.
2. M. F. Mushi, S. E. Mshana, C. Imirzalioglu, and F. Bwanga, "Car-bapenemase genes among multidrug resistant gram negative clinical isolates from a tertiary hospital in Mwanza, Tanzania," BioMed Research International, vol. 2014, Article ID 303104, 6 pages, 2014.
3. R. D. Smith and J. Coast, 'Antimicrobial resistance: a global response," Bulletin of the World Health Organization, vol. 80, no. 2, pp. 126-133, 2002.
4. Resistance USITFoA, 2009-2010 Progress Towards Implementation of: A Public Health Action Plan to Combat Antimicrobial Resistance, Interagency Task Force on Antimicrobial Resistance, 2011.
5. K. A. Johansson, D. Jerene, and O. F. Norheim, "National HIV treatment guidelines in Tanzania and Ethiopia: are they legitimate rationing tools?" journal of Medical Ethics, vol. 34, no. 6, pp. 478-483, 2008.
6. J. Vila, M. Vargas, C. Casals et al., "Antimicrobial resistance of diarrheagenic Escherichia coli isolated from children under the age of 5 years from Ifakara, Tanzania," Antimicrobial Agents and Chemotherapy, vol. 43, no. 12, pp. 3022-3024, 1999.
7. F. C. Tenover, "Mechanisms of antimicrobial resistance in bacteria," The American journal of Medicine, vol. 119, supplement 1, no. 6, pp. S3-S70, 2006.
8. H. Maortua, A. Canut, B. Ibáñez, D. Martínez, M. J. De Domingo, and A. Labora, "Relationship between in-hospital bacterial resistance and antimicrobial use over a 13-year period," Enfermedades Infecciosas y Microbiologia Clinica, vol. 27, no. 8, pp. 441-448, 2009.
9. A.-M. Rogues, C. Dumartin, B. Amadéo et al., "Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals," Infection Control and Hospital Epidemiology, vol. 28, no. 12, pp. 1389-1395, 2007
10. E. Iosifidis, C. Antachopoulos, M. Tsivitanidou et al., "Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece," Infection Control and Hospital Epidemiology, vol. 29, no. 7, pp. 615-622, 2008.
11. S. A. Madhi, K. Petersen, A. Madhi, M. Khoosal, and K. P. Klugman, "Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children," Clinical Infectious Diseases, vol. 31, no. 1, pp. 170-176, 2000.
12. M. Cheesborough, "Microbiology," in District Laboratory Practice in Tropical Countries Vol. II, pp. 158-195, Cambridge University Press, 2nd edition, 2006.
13. M. A. Wikler, Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement, Clinical and Laboratory Standards Institute, 2010.
14. M. J. Perilla, G. Ajello, C. Bopp et al., Manual for the Laboratory Identification and Antimicrobial Susceptibility Testing of Bacterial Pathogens of Public Health Importance in the Developing World: Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae, Neisseria gonorrhoeae, Salmonella serotype Typhi, Shigella, and Vibrio cholerae, Centers for Disease Control and Prevention, National Center for Infectious Diseases, 2003.
15. S. E. Mshana, E. Kamugisha, M. Mirambo, T. Chakraborty, and E. F. Lyamuya, "Prevalence of multi-resistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania," BMC Research Notes, vol. 2, article 49, 2009.
16. Jamii TWyAnUw, Programme NAC: National Guidelines for the Management of HIV and AIDS, National Aids Control Programme, 2008.
17. R. Zachariah, M. P. Spielmann, A. D. Harries, P. Gomani, and E. Bakali, "Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi," International journal of Tuberculosis and Lung Disease, vol. 6, no. 12, pp. 1046-1050, 2002.
18. WHO, Provisional WHO/UNAIDS Secretariat Recommendations on the Use of Cotrimoxazole Prophylaxis in Adults and Children Living with HIV/AIDS in Africa, WHO, Geneva, Switzerland, 2000.
19. E. Nelson, J. Kayega, J. Seni et al., "Evaluation of existence and transmission of extended spectrum beta lactamase producing bacteria from post-delivery women to neonates at Bugando Medical Center, Mwanza-Tanzania," BMC Research Notes, vol. 7, no. 1, article 279, 2014.
20. N. Kayange, E. Kamugisha, D. L. Mwizamholya, S. Jeremiah, and S. E. Mshana, "Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania," BMC Pediatrics, vol. 10, no. 1, article 39, 2010.
21. N. Moremi, M. E Mushi, M. Fidelis, P. Chalya, M. Mirambo, and S. E. Mshana, "Predominance of multi-resistant gram-negative bacteria colonizing chronic lower limb ulcers (CLLUs) at Bugando Medical Center," BMC Research Notes, vol. 7, no. 1, article 211, 2014.
22. S. G Morpeth, N. M. Thielman, H. O. Ramadhani et al., "Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania," journal of Acquired Immune Deficiency Syndromes, vol. 47, no. 5, pp. 585-591, 2008.
23. A. S. Karstaedt, M. Khoosal, and H. H. Crewe-Brown, "Pneumococcal bacteremia during a decade in children in Soweto, South Africa," Pediatric Infectious Disease journal, vol. 19, no. 5, pp. 454-457, 2000.
24. E. Leibovitz, G Dragomir, S. Sfartz et al., "Nasopharyngeal carriage of multidrug-resistant Streptococcus pneumoniae in institutionalized HIV-infected and HIV-negative children in northeastern Romania," International journal of Infectious Diseases, vol. 3, no. 4, pp. 211-215, 1999.
25. F. Ndugulile, R. Jureen, S. Harthug, W. Urassa, and N. Langeland, "Extended spectrum β-lactamases among Gram-negative bacteria of nosocomial origin from an Intensive Care Unit of a tertiary health facility in Tanzania," BMC Infectious Diseases, vol. 5, article 86, 2005.
26. I. Skippen, M. Shemko, J. Turton, M. E. Kaufmann, G Palmer, and N. Shetty, "Epidemiology of infections caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London," journal of Hospital Infection, vol. 64, no. 2, pp. 115-123, 2006.
27. S. Shakil, M. Akram, S. M. Ali, and A. U. Khan, "Acquisition of extended-spectrum β-lactamase producing Escherichia coli strains in male and female infants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors," Journal of Medical Microbiology, vol. 59, part 8, pp. 948-954, 2010.
28. J. Mermin, J. Lule, J. P. Ekwaru et al., "Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members," AIDS, vol. 19, no. 10, pp. 1035-1042, 2005.
29. M. F. Cotton, E. Wasserman, J. Smit, A. Whitelaw, and H. J. Zar, "High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enter-obacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa," BMC Infectious Diseases, vol. 8, article 40, 2008.
30. X. Anglaret, G. Chêne, A. Attia et al., "Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial," The Lancet, vol. 353, no. 9163, pp. 1463-1468, 1999.
31. S. G Morpeth, N. M. Thielman, H. O. Ramadhani et al., "Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania," Journal of Acquired Immune Deficiency Syndromes, vol. 47, no. 5, pp. 585-591, 2008.
32. I. N. Okeke, R. Laxminarayan, Z. A. Bhutta et al., "Antimicrobial resistance in developing countries. Part I: recent trends and current status," The Lancet Infectious Diseases, vol. 5, no. 8, pp. 481-493, 2005.
33. M. F. Mushi, S. E. Mshana, C. Imirzalioglu, and F. Bwanga, "Car-bapenemase genes among multidrug resistant gram negative clinical isolates from a tertiary hospital in Mwanza, Tanzania," BioMed Research International, vol. 2014, Article ID 303104, 6 pages, 2014.
34. R. D. Smith and J. Coast, 'Antimicrobial resistance: a global response," Bulletin of the World Health Organization, vol. 80, no. 2, pp. 126-133, 2002.
35. Resistance USITFoA, 2009-2010 Progress Towards Implementation of: A Public Health Action Plan to Combat Antimicrobial Resistance, Interagency Task Force on Antimicrobial Resistance, 2011.
36. K. A. Johansson, D. Jerene, and O. F. Norheim, "National HIV treatment guidelines in Tanzania and Ethiopia: are they legitimate rationing tools?" journal of Medical Ethics, vol. 34, no. 6, pp. 478-483, 2008.
37. J. Vila, M. Vargas, C. Casals et al., "Antimicrobial resistance of diarrheagenic Escherichia coli isolated from children under the age of 5 years from Ifakara, Tanzania," Antimicrobial Agents and Chemotherapy, vol. 43, no. 12, pp. 3022-3024, 1999.
38. F. C. Tenover, "Mechanisms of antimicrobial resistance in bacteria," The American journal of Medicine, vol. 119, supplement 1, no. 6, pp. S3-S70, 2006.
39. H. Maortua, A. Canut, B. Ibáñez, D. Martínez, M. J. De Domingo, and A. Labora, "Relationship between in-hospital bacterial resistance and antimicrobial use over a 13-year period," Enfermedades Infecciosas y Microbiologia Clinica, vol. 27, no. 8, pp. 441-448, 2009.
40. A.-M. Rogues, C. Dumartin, B. Amadéo et al., "Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals," Infection Control and Hospital Epidemiology, vol. 28, no. 12, pp. 1389-1395, 2007
41. E. Iosifidis, C. Antachopoulos, M. Tsivitanidou et al., "Differential correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece," Infection Control and Hospital Epidemiology, vol. 29, no. 7, pp. 615-622, 2008.
42. S. A. Madhi, K. Petersen, A. Madhi, M. Khoosal, and K. P. Klugman, "Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children," Clinical Infectious Diseases, vol. 31, no. 1, pp. 170-176, 2000.
43. M. Cheesborough, "Microbiology," in District Laboratory Practice in Tropical Countries Vol. II, pp. 158-195, Cambridge University Press, 2nd edition, 2006.
44. M. A. Wikler, Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement, Clinical and Laboratory Standards Institute, 2010.
45. M. J. Perilla, G. Ajello, C. Bopp et al., Manual for the Laboratory Identification and Antimicrobial Susceptibility Testing of Bacterial Pathogens of Public Health Importance in the Developing World: Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae, Neisseria gonorrhoeae, Salmonella serotype Typhi, Shigella, and Vibrio cholerae, Centers for Disease Control and Prevention, National Center for Infectious Diseases, 2003.
46. S. E. Mshana, E. Kamugisha, M. Mirambo, T. Chakraborty, and E. F. Lyamuya, "Prevalence of multi-resistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania," BMC Research Notes, vol. 2, article 49, 2009.
47. Jamii TWyAnUw, Programme NAC: National Guidelines for the Management of HIV and AIDS, National Aids Control Programme, 2008.
48. R. Zachariah, M. P. Spielmann, A. D. Harries, P. Gomani, and E. Bakali, "Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi," International journal of Tuberculosis and Lung Disease, vol. 6, no. 12, pp. 1046-1050, 2002.
49. WHO, Provisional WHO/UNAIDS Secretariat Recommendations on the Use of Cotrimoxazole Prophylaxis in Adults and Children Living with HIV/AIDS in Africa, WHO, Geneva, Switzerland, 2000.
50. E. Nelson, J. Kayega, J. Seni et al., "Evaluation of existence and transmission of extended spectrum beta lactamase producing bacteria from post-delivery women to neonates at Bugando Medical Center, Mwanza-Tanzania," BMC Research Notes, vol. 7, no. 1, article 279, 2014.
51. N. Kayange, E. Kamugisha, D. L. Mwizamholya, S. Jeremiah, and S. E. Mshana, "Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania," BMC Pediatrics, vol. 10, no. 1, article 39, 2010.
52. N. Moremi, M. E Mushi, M. Fidelis, P. Chalya, M. Mirambo, and S. E. Mshana, "Predominance of multi-resistant gram-negative bacteria colonizing chronic lower limb ulcers (CLLUs) at Bugando Medical Center," BMC Research Notes, vol. 7, no. 1, article 211, 2014.
53. S. G Morpeth, N. M. Thielman, H. O. Ramadhani et al., "Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania," journal of Acquired Immune Deficiency Syndromes, vol. 47, no. 5, pp. 585-591, 2008.
54. A. S. Karstaedt, M. Khoosal, and H. H. Crewe-Brown, "Pneumococcal bacteremia during a decade in children in Soweto, South Africa," Pediatric Infectious Disease journal, vol. 19, no. 5, pp. 454-457, 2000.
55. E. Leibovitz, G Dragomir, S. Sfartz et al., "Nasopharyngeal carriage of multidrug-resistant Streptococcus pneumoniae in institutionalized HIV-infected and HIV-negative children in northeastern Romania," International journal of Infectious Diseases, vol. 3, no. 4, pp. 211-215, 1999.
56. F. Ndugulile, R. Jureen, S. Harthug, W. Urassa, and N. Langeland, "Extended spectrum β-lactamases among Gram-negative bacteria of nosocomial origin from an Intensive Care Unit of a tertiary health facility in Tanzania," BMC Infectious Diseases, vol. 5, article 86, 2005.
57. I. Skippen, M. Shemko, J. Turton, M. E. Kaufmann, G Palmer, and N. Shetty, "Epidemiology of infections caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London," journal of Hospital Infection, vol. 64, no. 2, pp. 115-123, 2006.
58. S. Shakil, M. Akram, S. M. Ali, and A. U. Khan, "Acquisition of extended-spectrum β-lactamase producing Escherichia coli strains in male and female infants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors," Journal of Medical Microbiology, vol. 59, part 8, pp. 948-954, 2010.
59. J. Mermin, J. Lule, J. P. Ekwaru et al., "Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members," AIDS, vol. 19, no. 10, pp. 1035-1042, 2005.
60. M. F. Cotton, E. Wasserman, J. Smit, A. Whitelaw, and H. J. Zar, "High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enter-obacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa," BMC Infectious Diseases, vol. 8, article 40, 2008.
61. X. Anglaret, G. Chêne, A. Attia et al., "Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial," The Lancet, vol. 353, no. 9163, pp. 1463-1468, 1999.
62. S. G Morpeth, N. M. Thielman, H. O. Ramadhani et al., "Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania," Journal of Acquired Immune Deficiency Syndromes, vol. 47, no. 5, pp. 585-591, 2008.